In CLL, deregulations of various components of the telomere machinery such as length of telomeres, telomerase, and shelterin expression, and recurrent, activating POT1 mutations point to a global telomere dysfunction that plays an important role in disease pathogenesis and evolution. Here, POT1 is linked to B-cell chronic lymphocytic leukemia.